Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tomokazu TamuraTakashi IrieSayaka DeguchiHisano YajimaMasumi TsudaHesham NasserKeita MizumaArnon PlianchaisukSaori SuzukiKeiya UriuMst Monira BegumRyo ShimizuMichael JonathanRigel SuzukiTakashi KondoHayato ItoAkifumi KamiyamaKumiko YoshimatsuMaya ShofaRina HashimotoYuki AnrakuKanako Terakado KimuraShunsuke KitaJiei SasakiKaori Sasaki-TabataKatsumi MaenakaNaganori NaoLei WangYoshitaka Odanull nullTerumasa IkedaAkatsuki SaitoKeita MatsunoJumpei ItoShinya TanakaKei SatoTakao HashiguchiKazuo TakayamaTakasuke FukuharaPublished in: Nature communications (2024)
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.
Keyphrases
- sars cov
- structural basis
- respiratory syndrome coronavirus
- genome wide
- endothelial cells
- escherichia coli
- biofilm formation
- staphylococcus aureus
- pseudomonas aeruginosa
- hiv infected
- antiretroviral therapy
- induced pluripotent stem cells
- hiv infected patients
- angiotensin ii
- small molecule
- angiotensin converting enzyme
- protein protein
- cell free